Across contemporary cardiovascular clinical trials, the estimates of expected event rates and effect sizes that investigators use to calculate sample sizes—and funding requirements—often come in ...
Please provide your email address to receive an email when new articles are posted on . Patients treated with high-dose psilocybin had better responses compared with placebo in antidepressant trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback